Nicole Tsai

Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma

Robert Chen, Joycelynne Palmer, Peter Martin et al. · Biology of Blood and Marrow Transplantation · 2015 · 152 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Extramedullary Relapse Following Total Marrow and Lymphoid Irradiation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

Ji Hyun Kim, Anthony S. Stein, Nicole Tsai et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 41 citations

Medicine, Hematology, Oncology +14

Results of a Phase II Trial of Brentuximab Vedotin As First Line Salvage Therapy in Relapsed/Refractory HL Prior to AHCT

Robert W. Chen, Joycelynne Palmer, Peter Martin et al. · Blood · 2014 · 14 citations

Medicine, Hematology, Pharmacotherapy +8

Comparative Analysis of Autologous Hematopoietic Cell Transplantation with Radioimmunotherapy (RIT) Based Conditioning Versus Total Body Irradiation (TBI) for High-Risk Diffuse Large Cell Lymphoma (DLCL): Toxicity and Efficacy

Amrita Krishnan, Joycelynne Palmer, Auayporn Nademanee et al. · Blood · 2010 · 10 citations

Medicine, Hematology, Oncology +17